Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

University of Tennessee

Status: Active, not recruiting

Conditions: Proximal Muscle Lengthening; Proximal Muscle Strength

Treatments: Other: myofascial release; Device: blood flow restriction

Study type: Interventional

Funder types: Other

Identifiers

NCT05710757

22-08926-XP

Details and patient eligibility

About

The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.

Full description

The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein. Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response. Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy individuals between the age of 18 and 30

Exclusion criteria

• Individuals with uncontrolled high blood pressure
• Individuals with sickle cell anemia, current pregnancy
• Individuals with a history of deep vein thrombosis
• Individuals with diabetes
• Individuals with active infection
• Individuals with less than normal range of motion or muscle strength
• Individuals with moderate to severe upper extremity injury in the past 12 months
• Individuals with a current diagnosis of cancer.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Myofascial Release

Experimental group

Description:

The Experimental group will receive a myofascial release pectoralis minor release intervention.

Treatment:

Device: blood flow restriction

Other: myofascial release

Other: myofascial release

Sham Myofascial Release

Sham Comparator group

Description:

The Control group will receive a sham myofascial release pectoralis minor release intervention.

Treatment:

Device: blood flow restriction

Other: myofascial release

Other: myofascial release